Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma’s Influence on the Super Committee: Is Cash Really King?
PharmExec
Tuesday, August 16, 2011 - 10:06am
tags:
deficit, pharma industry
Take a Chance on Dendreon Corp
Seeking Alpha
Tuesday, August 16, 2011 - 10:05am
tags:
Dendreon, Provenge, prostate cancer
Ampio Pharmaceuticals' Bevy of Repositioned Products Could Make a Splash in Health Care
Seeking Alpha
Tuesday, August 16, 2011 - 10:04am
tags:
Ampion Pharmaceuticals, Ampio Pharmaceuticals, Optina, Zertane
Simcere Pharma Beats on Bottom Line
Yahoo/Zacks.com
Tuesday, August 16, 2011 - 9:31am
tags:
earnings, Simcere
Bullish on Optimer Pharma
Yahoo/Zacks.com
Tuesday, August 16, 2011 - 8:22am
tags:
Optimer, antibiotics, Dificid, Clostridium Difficile, Cubist Pharmaceuticals, ViroPharma
Teva’s Advance Swells Premium Over Tel Aviv: Israel Overnight
Bloomberg
Tuesday, August 16, 2011 - 8:20am
tags:
Teva Pharmaceuticals, Israel
Merck CEO, CFO Buy Shares After Stock Hits Low
Barron's
Monday, August 15, 2011 - 6:36pm
tags:
Merck, Pharma CEOs, Kenneth Frazier
J&J Recall Watch: Tylenol Cold Gelcaps Pulled
WSJ Online
Monday, August 15, 2011 - 6:31pm
tags:
JNJ, Tylenol, recalls
Drugmakers Seek End or Changes to U.S. Medication Naming Rules
Bloomberg
Monday, August 15, 2011 - 6:30pm
tags:
drug names, FDA, PhRMA
Dendreon and Provenge: Too High of a Risk for the Reward
Seeking Alpha
Monday, August 15, 2011 - 6:30pm
tags:
prostate cancer, Dendreon, Provenge, JNJ
Impax jumps 10% on Parkinson's study
Marketwatch
Monday, August 15, 2011 - 6:29pm
tags:
Impax, Parkinson's Disease, IPX066, GSK
China: The next biotech superpower?
CNN/Fortune
Monday, August 15, 2011 - 6:28pm
tags:
China, biotech
Government, generic industry reach agreement on fees
Fierce Pharma
Monday, August 15, 2011 - 12:27pm
tags:
generics, FDA
Roche licenses vemurafenib to Chugai
Pharmaceutical Business Review
Monday, August 15, 2011 - 12:25pm
tags:
Roche, vemurafenib, Chugai, melanoma, BRAF inhibitor
J&J, AZ nix Facebook pages on commenting rule change
Fierce Biotech
Monday, August 15, 2011 - 12:21pm
tags:
JNJ, AstraZeneca, Facebook, social media
Did Merck Fire Employee for Sleepwalking or for Refusing to Market Illegally?
AllGov
Monday, August 15, 2011 - 12:15pm
tags:
Merck, Ambien, HPV, Gardasil, lawsuits, drug reps
Big Pharma Banking on New Cancer Treatment Approach to Boost Sales
Investorplace
Monday, August 15, 2011 - 12:10pm
tags:
cancer, epigenetics, Celgene
Pharmaceutical sales rep sues employer for discriminating against her depression disability
Louisiana Record
Monday, August 15, 2011 - 12:08pm
tags:
discrimination, lawsuits, drug reps, Pamlab
Analysts see an upside after market swings bludgeon biotechs
Fierce Biotech
Monday, August 15, 2011 - 12:00pm
tags:
biotech, analysts
EntreMed posts $1.7M loss
Bizjournals.com
Monday, August 15, 2011 - 11:56am
tags:
earnings, EntreMed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.